Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-07-01Clinical Trial Update: Bleeding in Multiple Myeloma
A clinical trial registry entry for a study on bleeding in patients with multiple myeloma; the trial is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-06-24Clinical Trial Update: Primary Multiple Myeloma Who Achieved MRD Negativity After Induction Therapy, ASCT or Not
A recruiting clinical trial evaluating outcomes for primary multiple myeloma patients who achieved minimal residual disease negativity after…
-
CLINICAL_TRIALS research · 2024-06-21Clinical Trial Update: Daratumumab, Ixazomib, & Dexamethasone or Daratumumab, Bortezomib, & Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma [Phase 2]
This phase 2 clinical trial update describes two regimens for newly diagnosed multiple myeloma: daratumumab with ixazomib and dexamethasone,…
-
CLINICAL_TRIALS research · 2024-06-17Clinical Trial Update: COVID19 OutcomeS in Myeloma and the Impact of VaCcines
Clinical trial update noting an active-not-recruiting study investigating COVID-19 outcomes in patients with multiple myeloma and the impact…
-
CLINICAL_TRIALS research · 2024-06-17Clinical Trial Update: Selinexor Plus VRd in High Risk Newly Diagnosed Multiple Myeloma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating selinexor in combination with VRd (bortezomib, lenalidomide, dexamethasone) for high-risk newly diagnosed multi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-06-17Clinical Trial Update: ASH Research Collaborative Data Hub
The ASH Research Collaborative Data Hub trial is currently enrolling by invitation for Sickle Cell Disease and Multiple Myeloma. This entry …
-
CLINICAL_TRIALS research · 2024-06-14Clinical Trial Update: Evaluation of PET 18F-Fludarabine for the Initial Assessment and End-treatment of Symptomatic Multiple Myeloma Patients [Phase 1]
Phase 1 clinical trial evaluating PET imaging with 18F-fludarabine for initial assessment and end-treatment evaluation in symptomatic multip…
-
CLINICAL_TRIALS research · 2024-06-14Clinical Trial Update: A Survey on NINLARO Risk Management Plan (RMP) Material Utilization Among Pharmacists in Japan
A completed survey in Japan evaluating how pharmacists utilize Risk Management Plan materials for ixazomib (NINLARO) with results posted in …
-
CLINICAL_TRIALS research · 2024-06-13Clinical Trial Update: Clinical Outcomes and Prognostic Factors in Multiple Myeloma Patients
This clinical trial update discusses clinical outcomes and prognostic factors in patients with multiple myeloma. The study is not yet recrui…
-
CLINICAL_TRIALS research · 2024-06-12Clinical Trial Update: Study of CT071 Injection in High Risk Newly Diagnosed Multiple Myeloma [EARLY_Phase 1]
An early-phase (Phase 1) clinical trial evaluating CT071 injections in high-risk, newly diagnosed multiple myeloma is currently recruiting.
-
CLINICAL_TRIALS research · 2024-06-10Clinical Trial Update: PROSpECT-PRIOR-2-CHEMO: PRIOR Dental Intervention Before Chemo to Reduce Chemotherapy Complications [NA]
This trial update describes PROSpECT-PRIOR-2-CHEMO, a study evaluating a prior dental intervention before chemotherapy to reduce chemotherap…
-
CLINICAL_TRIALS research · 2024-05-31Clinical Trial Update: OriCAR-017 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of R/RMM [Phase 1, Phase 2]
Phase 1/2 clinical trial of OriCAR-017, a CAR-T cell therapy, for relapsed/refractory multiple myeloma, currently recruiting.
-
CLINICAL_TRIALS research · 2024-05-29Clinical Trial Update: Evaluation iNduction, Consolidation and Maintenance Treatment With Isatuximab , Carfilzomib, LEnalidomide and Dexamethasone [Phase 2]
A Phase 2 clinical trial evaluating induction, consolidation, and maintenance therapy with isatuximab, carfilzomib, lenalidomide, and dexame…
-
CLINICAL_TRIALS research · 2024-05-29Clinical Trial Update: Evaluate the Safety and Efficacy for Oral Mucositis Prevention of MIT-001 in Auto HSCT [Phase 2]
A Phase 2 trial evaluates MIT-001 for prevention of oral mucositis in patients undergoing autologous hematopoietic stem cell transplantation…
-
CLINICAL_TRIALS research · 2024-05-14Clinical Trial Update: Trial of an Investigational Drug After Rejecting the Relapse of an Allogeneic Transplant [Phase 1, Phase 2]
A Phase 1/Phase 2 study of an investigational drug for multiple myeloma in patients who have relapsed after an allogeneic stem cell transpla…
-
CLINICAL_TRIALS research · 2024-05-14Clinical Trial Update: MUK Nine b: OPTIMUM Treatment Protocol [Phase 2]
Phase 2 OPTIMUM treatment protocol update for MUK Nine b in multiple myeloma; the trial is currently ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: ASCT With Nivolumab in Patients With Multiple Myeloma [Phase 1, Phase 2]
This clinical trial update reports a Phase 1/2 study evaluating autologous stem cell transplantation augmented with nivolumab in patients wi…
-
CLINICAL_TRIALS research · 2024-05-03Clinical Trial Update: Evaluating the Uptake and Utility of Clinical Pathways for Newly Diagnosed Patients With Multiple Myeloma
A clinical trial update describing the recruitment status for evaluating clinical pathways in newly diagnosed multiple myeloma patients.
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: A Phase I/IIa Clinical Trial to Assess Feasibility, Safety and Antitumor Activity of Autologous SLAMF7 CAR-T Cells in Multiple Myeloma [Phase 1, Phase 2]
Phase I/IIa trial evaluating autologous SLAMF7 CAR-T cells for feasibility, safety, and antitumor activity in multiple myeloma.
-
CLINICAL_TRIALS research · 2023-12-29Clinical Trial Update: Targeting CD19 and BCMA CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]
A clinical trial evaluating CAR-T cells targeting CD19 and BCMA in relapsed or refractory multiple myeloma across Phase 1 and Phase 2.
-
CLINICAL_TRIALS research · 2023-06-02Clinical Trial Update: Safety and ASCT-related Symptom Burden Optimization of Tocilizumab in ASCT Following HD Melphalan Conditioning for Multiple Myeloma Patients [Phase 4]
Phase 4 clinical trial investigating safety and symptom burden optimization of tocilizumab as part of ASCT conditioning for multiple myeloma…
-
CLINICAL_TRIALS research · 2020-02-27Clinical Trial Update: Determining the Feasibility of MLN9708 as Maintenance After Allogeneic Stem Cell Transplant for Multiple Myeloma [Phase 2]
Phase 2 trial assessing MLN9708 as maintenance therapy after allogeneic stem cell transplant in multiple myeloma; study completed with resul…
-
CLINICAL_TRIALS research · 2019-09-06Clinical Trial Update: Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery
Clinical trial assessing electrophysiological biomarkers of chemotherapy-related cognitive impairment and recovery; study completed with pos…
-
CLINICAL_TRIALS research · 2019-07-23Clinical Trial Update: BT062 in Combination With Lenalidomide or Pomalidomide and Dexamethasone in Patients With Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 trial evaluating BT062 in combination with lenalidomide or pomalidomide and dexamethasone in patients with multiple myeloma; study…
-
CLINICAL_TRIALS research · 2019-06-25Clinical Trial Update: A Clinical Research of BCMA-Targeted CAR-T in B Cell Malignancies [Phase 1, Phase 2]
A clinical trial update on a BCMA-targeted CAR-T therapy investigated in B cell malignancies across Phase 1 and Phase 2.